# Postpartum Management of Gestational Hypertensive Disorders Using Furosemide

> **NCT04343235** · PHASE4 · TERMINATED · sponsor: **Wright State University** · enrollment: 13 (actual)

## Conditions studied

- Hypertension, Pregnancy-Induced

## Interventions

- **DRUG:** furosemide
- **DRUG:** labetalol

## Key facts

- **NCT ID:** NCT04343235
- **Lead sponsor:** Wright State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-05-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Challenges with enrollment; primary investigator left the institution
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04343235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04343235, "Postpartum Management of Gestational Hypertensive Disorders Using Furosemide". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04343235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*